Insight Advisors LLC PA Has $578,000 Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Insight Advisors LLC PA trimmed its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 2.2% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 1,391 shares of the healthcare conglomerate’s stock after selling 31 shares during the quarter. Insight Advisors LLC PA’s holdings in UnitedHealth Group were worth $578,000 at the end of the most recent quarter.

Other institutional investors have also bought and sold shares of the company. First Manhattan Co. increased its position in UnitedHealth Group by 19.7% during the first quarter. First Manhattan Co. now owns 1,482,677 shares of the healthcare conglomerate’s stock worth $551,661,000 after buying an additional 243,529 shares during the last quarter. GWM Advisors LLC grew its position in shares of UnitedHealth Group by 8.3% in the second quarter. GWM Advisors LLC now owns 31,240 shares of the healthcare conglomerate’s stock valued at $12,510,000 after purchasing an additional 2,397 shares during the last quarter. Veritas Asset Management LLP grew its position in shares of UnitedHealth Group by 0.4% in the first quarter. Veritas Asset Management LLP now owns 2,572,968 shares of the healthcare conglomerate’s stock valued at $957,324,000 after purchasing an additional 10,713 shares during the last quarter. Seven Springs Wealth Group LLC grew its position in shares of UnitedHealth Group by 58.6% in the second quarter. Seven Springs Wealth Group LLC now owns 2,544 shares of the healthcare conglomerate’s stock valued at $1,019,000 after purchasing an additional 940 shares during the last quarter. Finally, Reliant Investment Management LLC grew its position in shares of UnitedHealth Group by 2.0% in the first quarter. Reliant Investment Management LLC now owns 13,324 shares of the healthcare conglomerate’s stock valued at $4,957,000 after purchasing an additional 255 shares during the last quarter. 86.21% of the stock is currently owned by hedge funds and other institutional investors.

Several equities research analysts have recently issued reports on UNH shares. Cowen started coverage on UnitedHealth Group in a research report on Thursday, September 9th. They issued an “outperform” rating and a $478.00 price target on the stock. Citigroup increased their target price on shares of UnitedHealth Group from $450.00 to $480.00 and gave the company a “buy” rating in a research note on Friday, July 16th. Deutsche Bank Aktiengesellschaft increased their target price on shares of UnitedHealth Group from $418.00 to $421.00 and gave the company a “buy” rating in a research note on Tuesday, July 13th. Barclays increased their target price on shares of UnitedHealth Group from $435.00 to $465.00 and gave the company an “overweight” rating in a research note on Friday, July 16th. Finally, Seaport Global Securities initiated coverage on shares of UnitedHealth Group in a research note on Friday, July 9th. They issued a “buy” rating and a $450.00 target price for the company. Three equities research analysts have rated the stock with a hold rating, twenty have issued a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Buy” and an average target price of $444.04.

NYSE:UNH opened at $407.08 on Friday. UnitedHealth Group Incorporated has a 1 year low of $291.22 and a 1 year high of $431.36. The firm has a 50 day moving average of $415.77 and a 200-day moving average of $401.58. The company has a current ratio of 0.77, a quick ratio of 0.77 and a debt-to-equity ratio of 0.62. The stock has a market capitalization of $383.84 billion, a P/E ratio of 26.89, a price-to-earnings-growth ratio of 1.62 and a beta of 0.77.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Wednesday, July 14th. The healthcare conglomerate reported $4.70 earnings per share for the quarter, beating analysts’ consensus estimates of $4.43 by $0.27. The business had revenue of $71.32 billion during the quarter, compared to analyst estimates of $69.51 billion. UnitedHealth Group had a net margin of 5.33% and a return on equity of 22.15%. UnitedHealth Group’s revenue for the quarter was up 14.8% compared to the same quarter last year. During the same quarter last year, the business posted $7.12 earnings per share. As a group, analysts forecast that UnitedHealth Group Incorporated will post 18.74 EPS for the current fiscal year.

The business also recently declared a quarterly dividend, which was paid on Tuesday, September 21st. Investors of record on Monday, September 13th were issued a $1.45 dividend. This represents a $5.80 dividend on an annualized basis and a dividend yield of 1.42%. The ex-dividend date of this dividend was Friday, September 10th. UnitedHealth Group’s dividend payout ratio is currently 34.36%.

In other news, Director Stephen J. Hemsley sold 60,000 shares of the business’s stock in a transaction on Friday, July 16th. The shares were sold at an average price of $420.62, for a total value of $25,237,200.00. Following the completion of the transaction, the director now owns 941,560 shares of the company’s stock, valued at approximately $396,038,967.20. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CEO Andrew Witty sold 6,000 shares of the business’s stock in a transaction on Wednesday, July 21st. The shares were sold at an average price of $414.15, for a total transaction of $2,484,900.00. The disclosure for this sale can be found here. In the last three months, insiders sold 101,438 shares of company stock valued at $42,396,929. 0.55% of the stock is currently owned by company insiders.

UnitedHealth Group Company Profile

UnitedHealth Group, Inc engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum’s capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience.

Read More: What can cause a stock to outperform?

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.